PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Institute of Molecular Virology, Ulm University Medical Centre, Ulm, Germany.\', \'*equal contributions.\', \'Department of Internal Medicine, Ulm University Hospital, Ulm, Germany.\', \'Department of Chemistry and iNano Interdisciplinary Nanoscience Centre, Aarhus University, Aarhus, Denmark.\', \'#equal contribution and joint supervision.\', \'Department of Internal Medicine, Ulm University Hospital, Ulm, Germany alexander.kleger@uni-ulm.de.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.7861/clinmed.2020-0351
?:hasPublicationType
?:journal
  • Clinical medicine (London, England)
is ?:pmid of
?:pmid
?:pmid
  • 32863274
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Inhaled and systemic heparin as a repurposed direct antiviral drug for prevention and treatment of COVID-19.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all